1. Home
  2. INSM
  3. INSM News

Latest Insmed Incorporated (INSM) News on November 21, 2024

INSM

MT Newswires

2 days ago

Sector Update: Health Care Stocks Decline

INSM

MT Newswires

2 days ago

Sector Update: Health Care Stocks Mixed Tuesday Afternoon

INSM

MT Newswires

2 days ago

Insmed Terminates $500 Million Share Sale Agreement With Leerink

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
INSM

PR Newswire

14 days ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed To Present at November 2024 Investor Conferences
INSM

PR Newswire

15 days ago

Insmed To Present at November 2024 Investor Conferences

Insmed (INSM) Reliance on International Sales: What Investors Need to Know
INSM

Zacks

17 days ago

Insmed (INSM) Reliance on International Sales: What Investors Need to Know

Do You Believe in the Growth Potential of Insmed (INSM)?
INSM

Insider Monkey

20 days ago

Do You Believe in the Growth Potential of Insmed (INSM)?

Insmed's Q3 Loss Wider Than Expected, Sales In Line With Estimates
INSM

Zacks

20 days ago

Insmed's Q3 Loss Wider Than Expected, Sales In Line With Estimates

Insmed Third Quarter 2024 Earnings: EPS Misses Expectations
INSM

Simply Wall St.

20 days ago

Insmed Third Quarter 2024 Earnings: EPS Misses Expectations

Insmed Inc (INSM) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
INSM

GuruFocus.com

20 days ago

Insmed Inc (INSM) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

INSM

Thomson Reuters StreetEvents

20 days ago

Q3 2024 Insmed Inc Earnings Call

Decoding Insmed Inc (INSM): A Strategic SWOT Insight
INSM

GuruFocus.com

21 days ago

Decoding Insmed Inc (INSM): A Strategic SWOT Insight

Insmed (INSM) Reports Q3 Earnings: What Key Metrics Have to Say
INSM

Zacks

21 days ago

Insmed (INSM) Reports Q3 Earnings: What Key Metrics Have to Say

INSM

MT Newswires

21 days ago

Insmed Q3 Net Loss Widens, Revenue Rises

Insmed (INSM) Reports Q3 Loss, Tops Revenue Estimates
INSM

Zacks

21 days ago

Insmed (INSM) Reports Q3 Loss, Tops Revenue Estimates

INSM

Associated Press Finance

21 days ago

Insmed: Q3 Earnings Snapshot

Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update
INSM

PR Newswire

21 days ago

Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update

Insmed (INSM) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
INSM

Zacks

22 days ago

Insmed (INSM) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

How to play biotech stocks: Insmed and Wave Life Sciences
INSM

Yahoo Finance Video

23 days ago

How to play biotech stocks: Insmed and Wave Life Sciences

Insmed Ranks No. 1 on Science's 2024 Top Biopharma Employers List
INSM

PR Newswire

a month ago

Insmed Ranks No. 1 on Science's 2024 Top Biopharma Employers List

Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Should You Buy?
INSM

Zacks

a month ago

Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Should You Buy?

Insmed Unites Across Communities Around the World During Third Annual Global Day of Good
INSM

PR Newswire

a month ago

Insmed Unites Across Communities Around the World During Third Annual Global Day of Good

Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
INSM

Zacks

a month ago

Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024
INSM

PR Newswire

a month ago

Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024

INSM

MT Newswires

a month ago

Truist Securities Raises Insmed's Price Target to $100 From $85, Buy Rating Maintained

Insmed Inc (INSM) Q2 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...
INSM

GuruFocus.com

a month ago

Insmed Inc (INSM) Q2 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains?
INSM

Zacks

a month ago

Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains?

INSM

MT Newswires

a month ago

Insmed Reports Consistent Subgroup Data in Phase 3 Study of Brensocatib With Overall Trial Results

New Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Population Results
INSM

PR Newswire

a month ago

New Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Population Results

Insmed Inc. (INSM): Hedge Funds Are Bullish On This NASDAQ Stock Right Now
INSM

Insider Monkey

2 months ago

Insmed Inc. (INSM): Hedge Funds Are Bullish On This NASDAQ Stock Right Now

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
INSM

PR Newswire

2 months ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Is Insmed Incorporated (INSM) the Best Performing Long Term Stock in 2024?
INSM

Insider Monkey

2 months ago

Is Insmed Incorporated (INSM) the Best Performing Long Term Stock in 2024?

Is Insmed Inc. (INSM) the Best Performing Stock in 2024?
INSM

Insider Monkey

2 months ago

Is Insmed Inc. (INSM) the Best Performing Stock in 2024?

Insmed Inc. (INSM): A Top Mid-Cap Biopharma Stock with Compelling Growth Potential
INSM

Insider Monkey

2 months ago

Insmed Inc. (INSM): A Top Mid-Cap Biopharma Stock with Compelling Growth Potential

INSM

MT Newswires

2 months ago

Insmed Insider Sold Shares Worth $3,074,177, According to a Recent SEC Filing

INSM

MT Newswires

2 months ago

Insmed Insider Sold Shares Worth $2,072,223, According to a Recent SEC Filing

Insmed Incorporated (INSM) Surged Following Positive Data For its Drug
INSM

Insider Monkey

2 months ago

Insmed Incorporated (INSM) Surged Following Positive Data For its Drug

Insmed Incorporated (INSM): Hedge Funds Are Recommending This Biotech Stock Now
INSM

Insider Monkey

2 months ago

Insmed Incorporated (INSM): Hedge Funds Are Recommending This Biotech Stock Now

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
INSM

PR Newswire

2 months ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed (INSM) Rose Due to Positive Trial Results
INSM

Insider Monkey

3 months ago

Insmed (INSM) Rose Due to Positive Trial Results

Insmed Stock Surges 168% in the Past Six Months: Here's Why
INSM

Zacks

3 months ago

Insmed Stock Surges 168% in the Past Six Months: Here's Why

Meta Stock Leads 5 Names Near Buy Points As Market Bounces
INSM

Investor's Business Daily

3 months ago

Meta Stock Leads 5 Names Near Buy Points As Market Bounces

INSM

MT Newswires

3 months ago

Mizuho Adjusts Price Target on Insmed to $92 From $82, Maintains Outperform Rating

Insider Sale: Chief People Strategy Officer Schaeffer Orlov S Nicole Sells Shares of Insmed Inc ...
INSM

GuruFocus.com

3 months ago

Insider Sale: Chief People Strategy Officer Schaeffer Orlov S Nicole Sells Shares of Insmed Inc ...

INSM

MT Newswires

3 months ago

Insmed Insider Sold Shares Worth $686,408, According to a Recent SEC Filing

INSM

MT Newswires

3 months ago

Insmed Insider Sold Shares Worth $6,425,466, According to a Recent SEC Filing

Insmed Incorporated (NASDAQ:INSM) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
INSM

Simply Wall St.

3 months ago

Insmed Incorporated (NASDAQ:INSM) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Insmed Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
INSM

Simply Wall St.

3 months ago

Insmed Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Insmed (INSM) Lags on Q2 Earnings, Tops Sales, Reiterates View
INSM

Zacks

3 months ago

Insmed (INSM) Lags on Q2 Earnings, Tops Sales, Reiterates View

INSM

MT Newswires

3 months ago

UBS Adjusts Insmed Price Target to $84 From $78, Maintains Buy Rating

INSM

MT Newswires

3 months ago

Truist Adjusts Insmed's PT to $85 From $88, Keeps Buy Rating

Decoding Insmed Inc (INSM): A Strategic SWOT Insight
INSM

GuruFocus.com

3 months ago

Decoding Insmed Inc (INSM): A Strategic SWOT Insight

Compared to Estimates, Insmed (INSM) Q2 Earnings: A Look at Key Metrics
INSM

Zacks

3 months ago

Compared to Estimates, Insmed (INSM) Q2 Earnings: A Look at Key Metrics

Insmed (INSM) Reports Q2 Loss, Tops Revenue Estimates
INSM

Zacks

3 months ago

Insmed (INSM) Reports Q2 Loss, Tops Revenue Estimates

INSM

MT Newswires

3 months ago

Insmed Q2 Net Loss Widens, Revenue Increases

INSM

Associated Press Finance

3 months ago

Insmed: Q2 Earnings Snapshot

Insmed Reports Second-Quarter 2024 Financial Results and Provides Business Update
INSM

PR Newswire

3 months ago

Insmed Reports Second-Quarter 2024 Financial Results and Provides Business Update

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
INSM

PR Newswire

4 months ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Swelling losses haven't held back gains for Insmed (NASDAQ:INSM) shareholders since they're up 328% over 5 years
INSM

Simply Wall St.

4 months ago

Swelling losses haven't held back gains for Insmed (NASDAQ:INSM) shareholders since they're up 328% over 5 years

Analysts Estimate Axsome Therapeutics (AXSM) to Report a Decline in Earnings: What to Look Out for
INSM

Zacks

4 months ago

Analysts Estimate Axsome Therapeutics (AXSM) to Report a Decline in Earnings: What to Look Out for

Insmed to Host Second-Quarter 2024 Financial Results Conference Call on Thursday, August 8, 2024
INSM

PR Newswire

4 months ago

Insmed to Host Second-Quarter 2024 Financial Results Conference Call on Thursday, August 8, 2024

These Signs Show Which Stocks Are Having A Hidden Rally, Says Mark Minervini
INSM

Investor's Business Daily

4 months ago

These Signs Show Which Stocks Are Having A Hidden Rally, Says Mark Minervini

Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
INSM

Zacks

4 months ago

Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

What Makes Insmed Incorporated (INSM) a Prospective Investment?
INSM

Insider Monkey

4 months ago

What Makes Insmed Incorporated (INSM) a Prospective Investment?

INSM

MT Newswires

4 months ago

Goldman Sachs Raises Price Target on Insmed to $102 From $74, Maintains Buy Rating

INSM

MT Newswires

4 months ago

Guggenheim Adjusts Price Target on Insmed to $95 From $70, Maintains Buy Rating

INSM

MT Newswires

4 months ago

HC Wainwright Adjusts Price Target on Insmed to $90 From $70, Maintains Buy Rating

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
INSM

PR Newswire

5 months ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

More endpoints met in Insmed’s Phase III brensocatib trial
INSM

Clinical Trials Arena

5 months ago

More endpoints met in Insmed’s Phase III brensocatib trial

INSM

MT Newswires

5 months ago

Insmed Presenting More Positive Data for Prospective Drug Treatment for Bronchiectasis This Week

Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference
INSM

PR Newswire

5 months ago

Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference

Pharma companies shape competitive pipeline for bronchiectasis
INSM

Clinical Trials Arena

5 months ago

Pharma companies shape competitive pipeline for bronchiectasis

INSM

MT Newswires

5 months ago

Truist Adjusts Insmed PT to $88 From $68, Updates Model Post Commercial Day; Maintains Buy Rating

Insmed Announces Redemption of all $225 Million of Outstanding 1.75% Convertible Senior Notes Due 2025
INSM

PR Newswire

5 months ago

Insmed Announces Redemption of all $225 Million of Outstanding 1.75% Convertible Senior Notes Due 2025

INSM

MT Newswires

5 months ago

Evercore ISI Boosts Price Target on Insmed to $75 From $42, Maintains Outperform Rating

INSM

MT Newswires

5 months ago

JPMorgan Raises Insmed's Price Target to $72 From $55, Maintains Overweight Rating

Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
INSM

BioPharma Dive

5 months ago

Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing

INSM

MT Newswires

5 months ago

Insmed Insider Sold Shares Worth $1,271,700, According to a Recent SEC Filing

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
INSM

GOBankingRates

5 months ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
INSM

Business Insider

5 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women
INSM

Insider Monkey

5 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
INSM

Reuters

5 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

INSM

Insider Monkey

5 months ago

Best Date Night Fragrance in 2024

France's Macron calls snap legislative elections after EU poll blow
INSM

AFP

5 months ago

France's Macron calls snap legislative elections after EU poll blow

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events
INSM

Investor's Business Daily

5 months ago

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events

European Union Vote Delivers Shift to Right, in Blow to French and German Governments
INSM

The Wall Street Journal

5 months ago

European Union Vote Delivers Shift to Right, in Blow to French and German Governments

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
INSM

PR Newswire

5 months ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

INSM

MT Newswires

6 months ago

Insmed Insider Sold Shares Worth $3,043,150, According to a Recent SEC Filing

INSM

MT Newswires

6 months ago

UBS Raises Price Target on Insmed to $78 From $58, Maintains Buy Rating

INSM

MT Newswires

6 months ago

Stifel Adjusts Price Target on Insmed to $74 From $67, Maintains Buy Rating

Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference
INSM

PR Newswire

6 months ago

Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference

INSM

MT Newswires

6 months ago

Stifel Adjusts Price Target on Insmed to $67 From $39, Maintains Buy Rating

INSM

MT Newswires

6 months ago

Insmed Insider Sold Shares Worth $1,362,075, According to a Recent SEC Filing

INSM

MT Newswires

6 months ago

Insmed Insider Sold Shares Worth $6,316,579, According to a Recent SEC Filing

INSM

MT Newswires

6 months ago

Insmed Insider Sold Shares Worth $12,064,607, According to a Recent SEC Filing

INSM

MT Newswires

6 months ago

Insmed Insider Sold Shares Worth $2,215,081, According to a Recent SEC Filing

Insmed to Host Commercial Webinar on June 4, 2024
INSM

PR Newswire

6 months ago

Insmed to Host Commercial Webinar on June 4, 2024

INSM

MT Newswires

6 months ago

Insmed Prices $650 Million Public Offering

Insmed Announces Pricing of $650 Million Public Offering of Common Stock
INSM

PR Newswire

6 months ago

Insmed Announces Pricing of $650 Million Public Offering of Common Stock

Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data
INSM

Zacks

6 months ago

Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data

Share on Social Networks: